Management of First Episode Psychosis

Join Genomind and guest speaker, Dr. Craig Chepke, as they discuss the management of first episode psychosis. Craig Chepke, MD is a Board-Certified psychiatrist and has been named a Fellow of the American Psychiatric Association. He attended NYU School of Medicine and completed his residency training at Duke University. In addition to his clinical practice, Read More

Genomind – Psychiatric Case Roundtable

Join Genomind and our panel of experts for a psychiatric case roundtable with a focus on pharmacogenetics. Our panel features Dr. Judith Engelman, MD, Jennifer Reed, PMHNP-BC, and Dr. Rachel Shmuts, DO, PMH-C, and is moderated by members of Genomind’s Medical Affairs team, Dr. Seema Patel, PharmD, BCPP and Dr. Gabriela Williams, PharmD, BCPS, BCPP. Read More

Genomind – Pharmacogenetic Considerations for Treatment of the Geriatric Population

Join Genomind’s Vice President of Medical Affairs, Dr. Daniel Dowd, for a clinical presentation. Dr. Dowd discusses pharmacogenetic considerations that can be applied in the treatment of geriatric and comorbid patients. He also demonstrates how GenMed✓ Pro, Genomind’s precision gene-drug interaction software, can be utilized in the assessment of treatment options for this population.

NEW CentoXome – The Enhanced Whole Exome Sequencing (WES) Solution

It takes approx. seven years to diagnose a patient with a rare disease. It doesn’t have to be this way. We are excited to share that our enhanced Whole Exome Sequencing (WES) solution is now out! All WES samples received by our lab starting 1st June will be on this new enhanced CentoXome®. We are Read More